March 23 (Reuters) - Bonesupport Holding AB BONEX.ST :
* COMPANY WILL SUBMIT A DE NOVO APPLICATION TO US FOOD AND
DRUG
ADMINISTRATION (FDA) TO OBTAIN A MARKET APPROVAL FOR COMPANY'S
ANTIBIOTIC-RELEASING PRODUCT CERAMENT G
* APPLICATION CAN POTENTIALLY RESULT IN AN APPROVAL AT
LATTER END
OF 2020
* DIALOGUE WITH FDA HAS RESULTED IN CERAMENT G BEING GRANTED
DESIGNATION AS BREAKTHROUGH DEVICE
* CO HAS DECIDED TO SUBMIT A DE NOVO APPLICATION IN APRIL
2020
Source text for Eikon: ID:nWkr1t951Q
Further company coverage: BONEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))